ETRACS Whitney US Critical Technologies ETN

An intraday "indicative value" is used to measure the intrinsic value of each ETN and is for reference purposes only. Note: The market price (the actual trading price) of ETNs may be different from their indicative value.
Current Indicative Value
04/19/2024 | 03:55 pm
USD 30.77

Current Spot Price USD 30.79
04/19/2024 | 04:10 pm

Index Profile

Underlying Index	Solactive Whitney U.S. Critical Technologies CNTR Index
Ticker symbol	SOLUCTIC

About the index

The Index is a market-capitalization weighted index, subject to caps on individual companies, that is designed to track large- and mid-cap companies in developed markets that are associated with critical technology sectors and that meet a minimum “geopolitical risk rating score”. The Index selection criteria were developed by J.H. Whitney Data Services LLC and are in part based on critical technology areas established by the U.S. Department of Defense. The Underlying Index is an adjusted net total return index and the Index level reflects the notional reinvestment of the cash distributions from its constituent securities, subject to dividend withholding taxes, on distributions made by applicable non-U.S. Index Constituent Securities. No dividend withholding taxes are applied to distributions made by applicable U.S. Index Constituent Securities. The Underlying Index was first disseminated publicly on January 3, 2023 and has no live history prior to that date.

Index Historical Returns

Name	1 Month	3 Months	6 Months	1 Year	3 Years
Solactive Whitney U.S. Critical Technologies CNTR Index	-4.15%	2.47%	16.86%	18.28%	--

Source: UBS Investment Bank, publicly available data.

Historical information presented is furnished as a matter of information only. Historical performance of the Index is not an indication of future performance. Future performance of the Index may differ significantly from historical performance, either positively or negatively.

Index Historical Returns are calculated on the basis of intraday index levels or closing index levels where relevant.

Constituent Weightings

Name	Ticker symbol	% Weight
Microsoft	MSFT	5.47
Amazon.com	AMZN	4.97
Chevron	CVX	2.85
AbbVie	ABBV	2.49
Merck & Co.	MRK	2.49
Broadcom	AVGO	2.37
Pfizer	PFE	2.05
Thermo Fisher Scientific Inc.	TMO	2.00
Shell plc	SHELL	1.89
Salesforce	CRM	1.62
Abbott Laboratories	ABT	1.56
DHR Danaher Corp	DHR	1.49
Verizon Communications Inc.	VZ	1.42
BHP Group Limited	BHP	1.39
Adobe Systems	ADBE	1.39
COMCAST'A'	CMCSA	1.39
NextEra Energy Inc	NEE	1.35
Raytheon Technologies Corp	RTX	1.33
Bristol-Myers Squibb	BMY	1.30
AT&T Inc.	T	1.21
Honeywell	HON	1.19
Amgen	AMGN	1.13
LOCKHEED MARTIN	LMT	1.12
Intuit Inc	INTU	1.02
Medtronic	MDT	0.95
Applied Materials	AMAT	0.93
Gilead	GILD	0.92
Analog Devices	ADI	0.87
CSL LIMITED	CSL	0.82
AUTOMATIC DATA PROCESSING INC	ADP	0.81
Servicenow Inc.	NOW	0.78
PayPal	PYPL	0.76
Regeneron Pharma	REGN	0.72
T-Mobile US, Inc	TMUS	0.72
ZOETIS INC	ZTS	0.70
Vertex Pharmaceuticals	VRTX	0.69
Southern Co	SO	0.66
ILLINOIS TOOL WORKS	ITW	0.66
NORTHROP GRUMMAN CORP	NOC	0.64
Boston Scientific	BSX	0.63
Fiserv Inc	FISV	0.63
Lam Research Corp	LRCX	0.61
GSK PLC	GSK	0.61
General Dynamics	GD	0.55
Marathon Petro	MPC	0.55
Activision	ATVI	0.53
Synopsys Inc.	SNPS	0.51
Cadence Design	CDNS	0.51
Palo Alto	PANW	0.50
MercadoLibre Inc	MELI	0.50

Source: Solactive, as of March 14, 2023.

Constituent Weightings

Important legal information specific to ETRACS ETNs.

UBS AG has filed a registration statement (including a prospectus and supplements thereto) with the Securities and Exchange Commission, or SEC, for the offerings of securities to which this communication relates. Before you invest, you should read the prospectus, along with the applicable prospectus supplement, to understand fully the terms of the securities and other considerations that are important in making a decision about investing in the ETRACS. The applicable prospectus supplement for each ETRACS may be viewed by clicking on the ticker symbol of each ETRACS identified above. You may also view any of these documents without cost by visiting EDGAR on the SEC website at www.sec.gov. The securities related to the offerings are not deposit liabilities and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency of the United States, Switzerland or any other jurisdiction.

Disclaimer Business continuity

Important legal and regulatory information:

The products, services, information and/or materials contained within these web pages may not be available for residents of certain jurisdictions. Please consult the sales restrictions relating to the products or services in question for further information. Activities with respect to US securities are conducted through UBS Securities LLC, a US broker dealer. Member of SIPC

For information as to which entity provides the services in each jurisdiction click here.

The information in this section of the website may not be accessed in respect of any member state of the European Economic Area ("EEA") by persons who are retail investors. The securities referred to herein are not to be offered, sold or otherwise made available to any retail investor in the EEA and any person who is a retail investor in the EEA should not act or rely on this information or any of its contents. For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, "MiFID II"); (ii) a customer within the meaning of Directive 2002/92/EC (the "Insurance Mediation Directive"), where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II; or (iii) not a qualified investor as defined in Directive 2003/71/EC (as amended, the "Prospectus Directive").

The information in this section of the website may not be accessed in respect of the United Kingdom by persons who are retail investors. The securities referred to herein are not to be offered, sold or otherwise made available to any retail investor in the United Kingdom and any person who is a retail investor in the United Kingdom should not act or rely on this information or any of its contents. For these purposes, a retail investor means a person who is one (or more) of: a retail client as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (the "EUWA"); (ii) a customer within the meaning of the provisions of the Financial Services and Markets Act 2000 (the "FSMA") and any rules or regulations made under the FSMA to implement Directive (EU) 2016/97, where that customer would not qualify as a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA; or (iii) not a qualified investor as defined in Article 2 of the Prospectus Regulation as it forms part of domestic law by virtue of the EUWA ("UK Prospectus Regulation").